and ( d ) the optimum number of cytogenetically satisfactory prometaphase cells can be obtained with a 4-h exposure to a combination of low concentration actinomycin d ( 0.5 microgram/ml ) and colcemid ( 0.1 microgram/ml ) .
C0007634
the
C1450355
prometaphase